InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Sarepta Therapeutics, Inc.

SRPT Clue Score48
United States Fiscal year ends December CIK 0000873303 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Ian Michael Estepan
26 Feb 2026
Chief Operating Officer
Exercised, kept
5,381
$13.71
$73.77K
Ian Michael Estepan
26 Feb 2026
Chief Operating Officer
Exercised, kept
2,069
$13.71
$28.37K
Claude Nicaise
29 Jan 2026
Director
Exercised, kept
10,500
$13.71
$143.96K
M Kathleen Behrens
27 Jan 2026
Director
Exercised, kept
10,500
$13.71
$143.96K
Richard Barry
16 May 2025
Director
Exercised, kept
12,350
$32.63
$402.98K
Richard Barry
13 May 2025
Director
Exercised, kept
10,500
$13.71
$143.96K
Richard Barry
13 May 2025
Director
Exercised, kept
9,746
$25.18
$245.40K
Ian Michael Estepan
29 Jan 2025
Chief Financial Officer
Exercised, kept
1,533
$12.00
$18.40K
Ian Michael Estepan
29 Jan 2025
Chief Financial Officer
Exercised, kept
14,267
$12.00
$171.20K
M Kathleen Behrens
3 Jul 2024
Director
Exercised, kept
15,000
$13.90
$208.50K
M Kathleen Behrens
3 Nov 2023
Director
Exercised, kept
15,000
$29.03
$435.45K
M Kathleen Behrens
19 Dec 2022
Director
Exercised, kept
20,000
$34.92
$698.40K
M Kathleen Behrens
15 Dec 2021
Director
Exercised, kept
5,000
$10.08
$50.40K
Sandesh Mahatme
8 Jul 2020
EVP, CFO & Cbo
Exercised, kept
1,203
$32.63
$39.25K
Sandesh Mahatme
8 Jul 2020
EVP, CFO & Cbo
Exercised, kept
218
$13.71
$2.99K
Sandesh Mahatme
8 Jul 2020
EVP, CFO & Cbo
Exercised, kept
2,385
$13.71
$32.70K
M Kathleen Behrens
5 Sep 2019
Director
Exercised, kept
5,000
$7.80
$39.00K
Sandesh Mahatme
21 Aug 2019
EVP, CFO & Cbo
Exercised, kept
100,000
$23.85
$2.39M
Sandesh Mahatme
15 Aug 2019
EVP, CFO & Cbo
Exercised, kept
260
$13.71
$3.56K
Sandesh Mahatme
15 Aug 2019
EVP, CFO & Cbo
Exercised, kept
985
$13.71
$13.50K
Sandesh Mahatme
15 Aug 2019
EVP, CFO & Cbo
Exercised, kept
2,625
$13.90
$36.49K
Sandesh Mahatme
15 Aug 2019
EVP, CFO & Cbo
Exercised, kept
3,021
$29.03
$87.70K
Sandesh Mahatme
15 Aug 2019
EVP, CFO & Cbo
Exercised, kept
2,863
$34.92
$99.98K
Sandesh Mahatme
19 Mar 2019
EVP, CFO & Cbo
Exercised, kept
43
$13.71
$589.53
Sandesh Mahatme
19 Mar 2019
EVP, CFO & Cbo
Exercised, kept
164
$13.71
$2.25K
Sandesh Mahatme
19 Mar 2019
EVP, CFO & Cbo
Exercised, kept
3,511
$13.90
$48.80K
Sandesh Mahatme
19 Mar 2019
EVP, CFO & Cbo
Exercised, kept
11,768
$23.85
$280.67K
Sandesh Mahatme
15 Mar 2018
EVP, CFO & Cbo
Exercised, kept
2,500
$23.85
$59.63K
Alexander Cumbo
15 Mar 2018
SVP, Chief Commercial Officer
Exercised, kept
1,370
$26.24
$35.95K
Alexander Cumbo
15 Mar 2018
SVP, Chief Commercial Officer
Exercised, kept
835
$13.90
$11.61K
Alexander Cumbo
15 Mar 2018
SVP, Chief Commercial Officer
Exercised, kept
54
$13.71
$740.34
Alexander Cumbo
15 Mar 2018
SVP, Chief Commercial Officer
Exercised, kept
241
$13.71
$3.30K
David T Howton
15 Mar 2018
SVP, General Counsel
Exercised, kept
2,074
$23.85
$49.46K
David T Howton
15 Mar 2018
SVP, General Counsel
Exercised, kept
403
$13.90
$5.60K
David T Howton
15 Mar 2018
SVP, General Counsel
Exercised, kept
23
$13.71
$315.33
Shamim Ruff
15 Mar 2018
SVP, Chief Regulatory Affairs
Exercised, kept
2,031
$26.24
$53.29K
Shamim Ruff
15 Mar 2018
SVP, Chief Regulatory Affairs
Exercised, kept
469
$13.90
$6.52K
David T Howton
21 Jul 2017
SVP, General Counsel
Exercised, kept
676
$23.85
$16.12K
David T Howton
21 Jul 2017
SVP, General Counsel
Exercised, kept
324
$13.71
$4.44K
Sandesh Mahatme
21 Jul 2017
EVP, CFO & Cbo
Exercised, kept
1,500
$23.85
$35.78K
Edward M. MD Kaye
9 Nov 2016
President, CEO & CMO
Exercised, kept
3,000
$8.28
$24.84K
Sandesh Mahatme
9 Nov 2016
Senior Vice President, CFO
Exercised, kept
1,000
$23.85
$23.85K
David T Howton
9 Nov 2016
SVP, General Counsel
Exercised, kept
1,000
$23.85
$23.85K
Shamim Ruff
8 Nov 2016
SVP, Regulatory Affairs & Qual
Exercised, kept
1,000
$26.24
$26.24K
Show all 167 transactions →

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 63
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 4,825,682
Sales filed before the plan box existed 7
History held since 8 Feb 2007